에버엑스 단체사진.jpg
이미지 없음
Exhibition Participation History
#K-HOSPITAL+HEALTH TECH FAIR 2024 #K-HOSPITAL FAIR 2023 #K-HOSPITAL FAIR 2022 #DX KOREA 2022
Company Overview
Representative
Yunchan
Company Type
Service
Year founded
2019
Business
Service
Event
IT·Information Communication
Number of employees
50 to 299 people
Annual turnover
Less than KRW 1 billion
Address
29-7, Seoripul-gil, Seocho-gu, Seoul (Seocho-dong)
Featured Products
Digital solution for musculoskeletal rehabilitation exercise therapy
Representative number
+82-504-1361-1314

Company Introduction

A digital healthcare startup
rehabilitative procedures due to a variety of reasons including time, cost, and location limitation during his 10-year practice, although exercises are a pivotal part of the rehabilitation. He has identified and realized that accessibility is an issue to a wider patient population.

EverEx as a digital therapeutics startup aims to solve this very problem with focus on three things: (a) an objective evaluation of musculoskeletal conditions, (b) rehabilitative exercise programs designed by medical professionals, and (c) usability as distinctive, personalized user experiences.

EverEx aims to lead the digital therapeutics solution for musculoskeletal disorders as the first in South Korea. We are progressing to test the product, advance the pose-estimation technology with machine-learned data, and conduct clinical trials for an individual disorder through hospital partnerships.

Biz News

Opening a new era of rehabilitation treatment, EverX

Musculoskeletal disorders include muscles, nerves, tendon(tendon), ligament , It is a disease caused by damage to the musculoskeletal system, including bones and surrounding tissues, and the main cause is repeated stimulation or incorrect posture. In this case, surgical treatment is important, but rehabilitation treatment that can restore motor function before muscle loss and joint contracture progresses is important.

However, proper rehabilitation treatment is not currently provided in the domestic medical system. As the elderly population rapidly increases, the demand for rehabilitation treatment is increasing, but due to economic and physical constraints, there are no hospitals that can meet this demand span>. As a result, patients have to do rehabilitation exercises on their own using books or video materials, and of course, the treatment effect is bound to be minimal.

EverX is carrying out a rehabilitation movement to solve this problem of unmet need for rehabilitation. Developed the treatment platformMORA. Overcame the limitations of face-to-face treatment through non-face-to-face treatment methods, and improved treatment effectiveness through real-time communication between medical staff and patients. >It is the core of MORA. I met EverX CEO Yoon Chan and heard about MORA, and EverX’s future goals.

Representative of EverX Co., Ltd. 1 (1).jpg
EverX CEO Yoon Chan

Please introduce your company

EverX is a musculoskeletal disease digital healthcare company established in August 2019. . Before establishing the company, as an orthopedic specialist, I experienced the unmet need for rehabilitation exercise therapy while treating actual patients, and I founded the company with the vision of solving this problem through digital technology. . Currently, specialists in rehabilitation medicine and psychiatry and computer vision artificial intelligence research and development, software medical device development , 36 experts specializing in licensing, etc. gathered together to create MORA, a rehabilitation exercise solution for musculoskeletal diseases. We are developing digital treatment devices based on and MORA .

The company has been recognized for its technological prowess and commercialization capabilities in rehabilitation exercise solutions and digital therapy devices, and has been selected for the TIPS R&D program by the Ministry of SMEs and Startups. >, Samsung Electronics C-Lab Outside Program, Seoul Korea Health Industry Development Institute It has also been selected for the 3rd Health X Challenge Seoul, a Novartis open contest project. Also, last 5month, a series worth 8 billionbillion won A Successfully completed the investment and attracted a cumulative investment of 10.5 billion won.< /p>

In addition, our company has proactively acquired certifications necessary for quality and information protection. We have proven our medical device manufacturing and management quality capabilities through GMP and ISO13485 certifications, and ISO27001/27701 >We have also proven our ability to protect information at the level required by the global market.

Please tell us about your main business

MORA developed by EverX is an abbreviation for 'Mobile Orthopedic Rehabilitation Assistant' It is a rehabilitation exercise solution that provides a mobile treatment curriculum specialized for musculoskeletal diseases based on medical evidence. Patellofemoral pain syndrome, mainly caused by musculoskeletal diseases such as chronic back pain 22 We provide an extensive rehabilitation exercise therapy curriculum for dog areas, and we directly developed a posture estimation model specialized for musculoskeletal estimation and applied it to MORA. In particular, MORA -based digital therapy devices apply cognitive behavioral therapy developed by psychiatrists and psychological counselors to improve the effectiveness and Increased compliance.

MORA and MORA -based digital treatment devices largely consist of a prescription web for medical staff and a mobile app for patients. span>. Once the medical staff configures and prescribes a treatment program suitable for the patient, the patient can perform the rehabilitation exercise therapy curriculum using the mobile device and the camera mounted on the device. Data collected during the exercise process is shared in real time with medical staff and patients to monitor performance rate and provide timely feedback to ensure functional improvement and treatment effectiveness.

MORA is currently being used by over 20 institutions and has been launched on the same platform in the United States.< span>. It is a product targeting remote treatment monitoring fee that does not exist in Korea and was recently registered as a medical device by FDA . This means that our product has public trust and its usability has been recognized by various medical institutions.

What are your future goals

The immediate goal is to increase the number of subscription-type customers for MORA in Korea, and the digital therapy device is undergoing exploratory clinical trials. 2Obtaining meaningful results from species is one of the goals. Based on these results, confirmatory clinical trials to receive approval from the Ministry of Food and Drug Safety are also planned to begin in the first half of next year. Also, at the end of this year, one of the company's core technologies, 'AI specialized in musculoskeletal analysis < span>Pose estimation' Motion analysis medical device using model 'MORA Vu' approved by the Ministry of Food and Drug Safety Expecting. Through this, medical institutions will be able to perform terminal-based motion analysis tests with minimal space and cost burden..

In the mid- to long-term, MORA is also expected to enter the U.S. market, where it can be used as a medical device for remote treatment monitoring . Last 7month 'EverEx Rehab' Product < span>We completed registration as a medical device with the FDA, and the company is collaborating with local clinics in the U.S. from the end of this year to pilot 'EverEx Rehab'. We plan to release a product next year that reflects customer feedback after a period of use..

In addition, as Korea's first digital treatment device in the musculoskeletal field, medical institutions can use MORA through health insurance coverage, and not only medical staff but also patients can access the web span>-I want to create an era in which app-based treatment devices are widely accepted. Also, as the number of actual users of MORA and digital treatment devices expands, AI functions It depicts the future of MORA, which automatically recommends a rehabilitation exercise curriculum based on the evaluation and the speaker's exercise performance and further predicts the prognosis of the disease. .

Contact Seller

You can use more services by logging in

Certification details

의료기기 품질관리 심사(GMP) 인증서.jpeg
의료기기 품질관리 심사(GMP) 인증서.jpeg
이노비즈(기술혁신형 중소기업) 인증서.jpg
이노비즈(기술혁신형 중소기업) 인증서.jpg
품질경영시스템(ISO13485) 인증서.jpg
품질경영시스템(ISO13485) 인증서.jpg
정보보호경영시스템(ISO27001) 인증서(국문).jpg
정보보호경영시스템(ISO27001) 인증서(국문).jpg
정보보호경영시스템(ISO27701) 인증서(국문).jpg
정보보호경영시스템(ISO27701) 인증서(국문).jpg